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Fli-1 Is Required for Murine Vascular and
Megakaryocytic Development and Is Hemizygously
Deleted in Patients with Thrombocytopenia
Introduction
The Fli-1 proto-oncogene is a member of the ETS family
of winged helix-turn-helix transcription factors that bind
a purine-rich consensus sequence GGA(A/T) (Nye et al.,
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the mammalian Fli-1 gene have been identified in several
other vertebrates, including quail (Mager et al., 1998),
Xenopus (Meyer et al., 1995), and zebrafish (Brown etSummary
al., 2000). The sequence of Fli-1 and its expression in
developing vascular endothelial cells is highly con-
The ETS gene Fli-1 is involved in the induction of eryth- served throughout vertebrate evolution.
roleukemia in mice by Friend murine leukemia virus The biological function of Fli-1 has been addressed
and Ewings sarcoma in children. Mice with a targeted by examining its DNA binding specificity, pattern of ex-
null mutation in the Fli-1 locus die at day 11.5 of em- pression during development, and phenotypic effects
bryogenesis with loss of vascular integrity leading to in mutant mice. In cell culture experiments, Fli-1, and/
bleeding within the vascular plexus of the cerebral or closely related members of the ETS family, bind to
enhancer sequences and transactivate a number ofmeninges and specific downregulation of Tek/Tie-2,
genes involved in vasculogenesis, hematopoiesis, andthe receptor for angiopoietin-1. We also show that
cell adhesion, including the endothelial-specific vascu-dysmegakaryopoiesis in Fli-1 null embryos resembles
lar endothelial±cadherin (VE-CAD) (Gory et al., 1998),that frequently seen in patients with terminal deletions
Tek/Tie-2 (Dube et al., 1999), intercellular cellular adhe-of 11q (Jacobsen or Paris-Trousseau Syndrome). We
sion (I-CAM) genes (de Launoit et al., 1998), and themap the megakaryocytic defects in 14 Jacobsen pa-
megakaryocyte-specific genes glycoprotein IIB (GpIIb)tients to a minimal region on 11q that includes the Fli-1
(Zhang et al., 1993), GpIX (Bastian et al., 1996), Von
gene and suggest that dysmegakaryopoiesis in these Willebrand factor (VWF) (Schwachtgen et al., 1997), and
patients may be caused by hemizygous loss of Fli-1. platelet factor 4 (PF4) (Lemarchandel et al., 1993). In
addition, overexpression of Fli-1 in K562 cells correlates
with, and can induce, megakaryocytic differentiation8 To whom correspondence should be addressed (e-mail: hart@
mshri.on.ca). (Athanasiou et al., 1996).
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Figure 1. Targeting the Fli-1 Gene
(A) The targeting strategy. The FliresZ and PNTFliZ targeting constructs replace the DNA binding (ETS) domain of Fli-1 with a b-galactosidase
(LacZ) reporter cassette and puromycin- or neomycin-resistance cassettes. RI, EcoRI; HIII, HindIII; B, BamHI.
(B) Targeted ES cell clones were isolated following electroporation of the R1 cell line and positive/negative selection in G418 (PNTFliZ) or
puromycin (FliresZ) and gancyclovir followed by screening of EcoRI-digested DNA by Southern analysis with a 59 external probe (probe 1).
One of four clones obtained by screening of 800 independent PNTFliZ-transformed clones is shown in lane 3.
(C) Germline transmission was confirmed in the progeny of chimeric mice by Southern analysis of BamHI-digested tail DNA with an external
39 probe (probe 2).
(D) Homozygous Fli-12/2 ES cell lines were established following transformation of a PNTFliZ-targeted cell line (lanes 1, 2, and 3) with FliresZ,
selection in puromycin and gancyclovir and Southern analysis of BamHI-digested DNA with a 39 external probe (probe 2). Two independent
Fli-12/2 cell lines are shown in lanes 3 and 4.
(E) Western analysis of E9.5 whole-embryo proteins probed with Fli-1 antiserum (Zhang et al., 1995). The Fli-1-specific 51 kDa band is present
in wild-type (lane 1) and at a reduced level in heterozygote (lane 2) but is absent in the Fli-12/2 homozygous mutant (lane 3).
We have previously described the generation of mu- Friend virus integration, consistent with the conclusion
that the targeted Fli-1 locus in these previous studiestant mice with either gain- or loss-of-function mutations
in Fli-1. Transgenic mice carrying the murine Fli-1 cDNA was not a null allele (Melet et al., 1996).
Therefore, to evaluate further the role of Fli-1 in mam-under the control of the H-2Kk promoter express Fli-1
at high levels in the spleen and thymus, exhibit increased malian development, we have generated, by gene tar-
geting, ES cells and embryos with a null Fli-1 mutation.lymphopoiesis, and develop a severe autoimmune dis-
ease culminating in glomerular nephritis (Zhang et al., Phenotypic analysis of mutant and chimeric embryos
demonstrated essential functions for Fli-1 in embryo-1995). In contrast, mice with a targeted hypomorphic
mutation in Fli-1 are viable but display a mild defect genesis, with Fli-12/2 embryos dying at midgestation
with marked defects in vascular development and mega-in lymphopoiesis (Melet et al., 1996). The hypomorphic
Fli-1 allele expresses low levels of a truncated Fli-1 pro- karyopoiesis.
tein that arises from an internal translational initiation
site and alternative splicing around the neo-selectable
Resultsmarker. This mutant protein retains the known functional
domains of Fli-1, including the N-terminal transactiva-
tion domain and the DNA binding ETS domain. In addi- Targeting of the Fli-1 Locus
To address the biological function of Fli-1 in vivo, wetion, homozygous Fli-1TP/TP mice retained susceptibility
to erythroleukemia induction by Friend virus, although generated mice carrying a germline mutation in Fli-1
by homologous recombination in embryonic stem (ES)the latency period was significantly increased. Impor-
tantly, the mutated Fli-1 allele remained a target for cells. We constructed two targeting vectors, PNTFliZ
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targeted lacZ reporter cassette during embryogenesis.Table 1. Embryonic Lethality of Fli-1 Mutants
Whole-mount staining for b-galactosidase activity pro-
Fli-1 Genotype duced a pattern of gene expression consistent with that
previously observed by RNA in situ hybridization forAge 1/1 1/2 2/2
murine Fli-1 (Melet et al., 1996) (Figure 2B). At embryonic
E7.5 5 13 4 day 8.0, expression was restricted to endothelial cells
E8.5 8 16 6
comprising the vascular plexus of the extraembryonicE9.5 12 28 10
visceral yolk sac and individual cells within the bloodE11.5 20 54 4
islands (data not shown). Vasculogenesis within the yolkE12.5 16 48 2a
sac was unaffected in Fli-12/2 mutants at this stage. ByE15 9 26 0
4 weeks 19 45 0 embryonic day 9.5, high levels of Fli-1 expression were
evident throughout the developing vasculature and en-Progeny of Fli-11/2 heterozygote intercrosses genotyped at five time
docardium. Expression of the LacZ reporter proteinpoints during embryonic (E) development and at weaning (4 weeks).
reached a maximum around E10.5 (Figure 3A). At thisa Fli-1 null embryos that survived until E12.5 were severely hemor-
stage, expression was highest in vascular endothelialrhaged.
cells and the endocardium of the heart. The intersomitic
blood vessels, aorta, and cerebral blood vessels also
exhibited high levels of Fli-1 expression, while lowerand FliresZ (Figure 1A), designed to replace the DNA
expression was observed in the peripheral blood vesselsbinding (ETS) domain in exon 9 with a lacZ reporter
and otic cup.gene and a cassette for positive selection of transformed
Vasculogenesis and angiogenesis in the embryo ap-colonies. Two independently targeted ES cell clones
peared normal until E11.5±E12.5 when multifocal intra-were isolated for each construct (Figure 1B) and aggre-
cranial hemorrhages began to appear (Figure 2C). Highgated with CD-1 embryos to produce chimeric founders,
levels of LacZ expression were detected in endothelialand germline transmission was achieved following mat-
cells of the midbrain and forebrain meninges at the sitesings between chimeric males and CD-1 or C57BL/6 fe-
where hemorrhages had occurred. Bleeding at thesemales (Figure 1C). Independent lines of mutant mice
sites appeared to be the result of disruption of the vascu-were generated from both PNTFliZ- (Fli-1Z/Z) and FliresZ-
lar plexus, possibly due to attenuation of the cell±cell(Fli-1LZ/LZ ) targeted ES clones, then backcrossed at least
adhesion between the endothelial cells that comprisefour times onto the C57BL/6 strain prior to phenotypic
the meninges (Figure 2D).analysis. Homozygous Fli-12/2 mutants presented here
carry the Fli-1LZ/LZ allele unless otherwise indicated. We
also derived homozygous mutant Fli-1Z/LZ ES cell clones Fli-12/2 Cells Are Lost from the Vasculature
in order to assess their differentiation capacity and abil- and Fetal Liver of Chimeric Embryos
ity to contribute to all tissues in competition with wild- In order to determine if Fli-1-deficient embryonic stem
type ES cells in chimeric mice. The Fli-1 null ES cells cells were intrinsically impaired in their capacity to com-
were generated following retargeting of PNTFliZ-tar- plete differentiation in any of the cell lineages in the
geted heterozygous cell lines with the FliresZ vector, embryo, we generated Fli-12/2 ES cells and aggregated
selection in puromycin, and screening by Southern anal- these cells with CD-1 morula stage embryos to produce
ysis (Figure 1D). Western analysis of proteins from E9.5 chimeric mice. Chimeric analysis makes it possible to
embryos with Fli-1-specific antiserum (Zhang et al., assay the development and proliferative potential of
1993) demonstrated a reduction of Fli-1 protein in het- cells lacking a specific gene(s) within the context of a
erozygous mutants and a complete loss of detectable normal developing organism and to identify any late-
Fli-1 protein in mutant embryos (Figure 1E). Similarly, acting effects of a gene by rescuing tissue-specific de-
Fli-1 transcripts were absent in homozygous mutant em- fects in the early embryo (for example, see Shalaby et
bryos at E9.5 (Figure 5, top panel). al., 1995; Puri et al., 1999). We then examined the ability
of the Fli-12/2 cells to contribute to the developing vascu-
Embryonic Lethality at E11.5 lature of the meninges and major cerebral blood vessels,
Heterozygous Fli-11/2 mice were viable, fertile, and phe- the endocardium, and megakaryocytes. Chimeric mice
notypically indistinguishable from their wild-type lit- generated from aggregations of CD-1 embryos with two
termates. The F1 progeny of Fli-11/2 matings were geno- independent Fli-11/2 heterozygous cell lines and two
typed by Southern analysis at 4 weeks of age (Figure Fli-12/2 cell lines (Figure 1D, lanes 4 and 5) were analyzed
1C). No viable Fli-12/2 homozygotes were identified, and, by whole-mount b-galactosidase staining and histologi-
as we did not observe any postnatal mortality in this cal examination at E10.5, E12.5, E14.5, and 6 weeks of
cross, we proceeded with analysis of embryonic viabil- age. We found that heterozygous and homozygous Fli-1
ity. Therefore, we screened embryos from heterozygous mutant ES cells were equally competent to contribute
Fli-11/2 matings at embryonic days 7.5, 8.5, 9.5, 11.5, to all tissues of chimeric embryos at E10.5, as judged
12.5, and 15 by PCR of DNA extracted from embryonic by the contribution of the AA isoform of glucose-6-phos-
yolk sac or tail. Fli-12/2 homozygous embryos were pres- phate isomerase (GPI) from the targeted R1 ES cells
ent up to 12.5 dpc (Table 1), but most displayed obvious (Nagy and Rossant, 1993) (data not shown). However,
intracranial hemorrhaging in the midbrain/forebrain by E12.5, significantly fewer LacZ-expressing cells were
boundary and in the hindbrain during early to midgesta- observed in the cerebral meninges of chimeric embryos
tion, between E9.5 and 11.5 (Figure 2A). derived from Fli-12/2 aggregations, compared with con-
trol Fli-11/2 aggregations, and LacZ-expressing cells
were not observed at all by E14.5 (compare Figures 3AFli-1 Expression and Hemorrhage
To understand the midgestation lethality in Fli-12/2 em- and 3D). Fli-12/2 cells were also compromised in their
ability to contribute to the vascular endothelium of thebryos, we first examined the temporal and tissue-spe-
cific expression of Fli-1 by following expression of the major cerebral blood vessels (compare Figures 3B and
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Figure 2. Embryonic Lethality due to Hemor-
rhage around E11.5
(A) Fli-1 Heterozygote and homozygote at day
11.5 of development. Homozygous Fli-12/2
embryos that were alive at E11.5 had signifi-
cant intracranial hemorrhages.
(B) Fli-1 expression assessed by whole-
mount b-galactosidase staining of a Fli-1 het-
erozygote at E11.5. Intersomitic blood ves-
sels (small arrow) and major cerebral blood
vessels (large arrow). Magnification, 53.
(C) Fli-1 expression assessed by b-galactosi-
dase activity is present at the sites of in-
tracranial hemorrhage. Saggital section of
E11.5 Fli-12/2 homozygote. Intracranial hem-
orrhages (arrows) are present in the forebrain.
Magnification, 103. Asterisk shows arrow in-
dicating area shown at higher magnification.
(D) Higher magnification of E11.5 Fli-12/2 sag-
gital section. Magnification, 503. Endothelial
cells of the forebrain meninges expressing
the lacZ reporter appear attenuated and dis-
continuous (arrow)
3E). Taken together, these results suggest that the loss progenitors migrate to the fetal liver, prior to definitive
hematopoiesis. Between E10.5 and E12.5, many LacZ-of Fli-1 leads to a cell-autonomous defect, which mani-
expressing cells were present in the fetal liver, the majorfests in a lower proliferative capacity or increased apo-
site of hematopoiesis during midgestation. Later in ges-ptosis of endothelial cells. Similarly, we found that Fli-
tation and in the adult, LacZ reporter expression was1-deficient cells had a severely reduced capacity to
restricted to large, multinucleated AChE-positive cellscontribute to the fetal liver. Heterozygous Fli-11/2 cells
in the spleen and liver.expressing the LacZ reporter were abundant within the
Total cell counts of peripheral blood from adult Fli-11/2livers of Fli-11/2;CD-1 chimeric mice at E14.5, but very
heterozygotes indicated that both red and white bloodfew Fli-12/2 cells expressing LacZ could be detected in
cells, hemoglobin, hematocrit, mean cell volume, plate-Fli-12/2;CD-1 chimeras at this stage (compare Figures
lets, and mean platelet volume were not significantly3C and 3F). Similarly, Fli-11/2 ES cell lines contributed
different from that of wild-type littermates (data notto the megakaryocyte lineage within the bone marrow
shown). In addition, heterozygous Fli-11/2 adult miceof adult chimeric mice, while Fli-12/2 megakaryocytes
displayed normal platelet function measured by durationcould not be detected (data not shown). The relative
of bleeding from tail cuts. To characterize hematopoieticcontribution of Fli-12/2 ES cell lines and CD-1 embryonic
progenitors in embryos lacking Fli-1, fetal liver cells werecells within the chimeric embryos was determined by
isolated from E11.5 embryos and plated in methylcellu-chromatography of GPI isoforms (Figure 3G), and em-
lose media supplemented with cytokines. The relativebryos with approximately equal proportions of each iso-
numbers of erythroid, macrophage, granulocyte, andform were analyzed.
mixed progenitors were not significantly different in
Fli-12/2 homozygotes compared to their heterozygous
Fli-12/2 Megakaryocytes Are Blocked Early or wild-type littermates (data not shown).
in Differentiation Megakaryopoiesis was evaluated in hematopoietic
Fli-1 activation following F-MuLV proviral insertion progenitors derived from E11.5 fetal liver by colony-
causes erythroleukaemia in mice (Ben David et al., 1991), forming assays in collagen-based media supplemented
and altered levels of Fli-1 expression have been associ- with thrombopoietin (Tpo), IL-3, IL-6, and IL-11. Mega-
ated with both erythroid and megakaryocytic differentia- karyocyte colonies that stained positive for acetylcholin-
tion (Athanasiou et al., 1996; Tamir et al., 1999). There- esterase (AChE) were counted after 6 days. The relative
fore, we examined the expression of the LacZ reporter number of megakaryocyte progenitors was elevated in
in these lineages and assessed the proliferative and Fli-12/2-deficient mice compared with wild-type and het-
differentiation capacity of erythroid and megakaryocyte erozygous littermates (p . 0.0001 in unpaired t test)
progenitors in colony-forming assays. Expression of the (Figure 4A). Cytological analysis of mutant and wild-type
LacZ reporter was detected within blood islands of the colonies revealed an increase in colonies containing
extraembryonic visceral yolk sac, coincident with com- small megakaryocytes with round nuclei and low nu-
mon progenitors of endothelial and hematopoietic lin- clear/cytoplasmic ratios characteristic of undifferenti-
eages. Circulating blood cells expressing LacZ were ated phenotypes (compare Figures 4B and 4C). Trans-
mission electron microscopy of Fli-12/2and Fli-11/2 E11.5observed between E8.5 and E10.5 at a time when early
Fli-1 in Vascular Development and Megakaryopoiesis
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Figure 3. Analysis of Fli-11/2 and Fli-12/2 ES Cell Contribution to Endothelial and Megakaryocyte Lineages in E14.5 Chimeric Embryos
(A) Fli-11/2;CD-1 chimera, saggital section. Fli-11/2 cells were identified in the meninges by LacZ expression (arrow).
(B) Fli-11/2;CD-1 chimera, coronal section. Arrow indicates interior carotid artery.
(C) Fli-11/2;CD-1 chimera, fetal liver. Arrow indicates megakaryocytes in the liver of E14.5 chimeric mice.
(D) Fli-12/2;CD-1 chimera, saggital section.
(E) Fli-12/2;CD-1 chimera, coronal section.
(F) Fli-12/2;CD-1 chimera, fetal liver section. Reduced numbers of Fli-12/2 (LacZ-expressing) cells were detected in the livers of E14.5 chimeric
mice (arrow).
(G) Analysis of glucose-6-phosphate isomerase (GPI) activity in chimeric embryos. Chimeric embryos with approximately equal contribution
from mutant R1 ES cells (GPIAA isoform) and CD-1 morula stage embryos (GPIBB isoform) were selected for analysis. Lane 1: ES cells; lanes
2, 3, 4, 5, 6, and 7: chimeric embryos shown in (A), (B), (C), (D), (E), and (F), respectively; lane 8: CD-1 embryo.
fetal liver revealed abnormal ultrastructural features in RNA transcripts for the Tek/Tie-2 and GpIX genes were
markedly reduced in Fli-12/2 embryos at this stage (Fig-the mutant megakaryocytes. Many of the megakaryo-
cytes analyzed in Fli-12/2 embryos shared a common ure 5). Transcripts corresponding to the cell adhesion
genes VE-CAD (Gory et al., 1998), and I-CAM-1 (de Lau-appearance not observed in the Fli-11/2 sections, includ-
ing reduced numbers of a granules, disorganization of noit et al., 1998) and hematopoietic genes c-kit (Ratajc-
zak et al., 1998) and c-fms (Ross et al., 1998) were alsothe platelet demarcation membranes, and reduced over-
all size (compare Figures 4D and 4E). examined and found to be equivalent in heterozygous
Fli-11/2 and mutant Fli-12/2 embryos at this stage (data
not shown).Regulation of Endothelial- and Megakaryocyte-
Specific Genes in Fli-1 Mutant Embryos
The transcriptional regulation regions of a number of Dysmegakaryopoiesis in Jacobsen Syndrome
Maps to 11q24endothelial- and megakaryocyte-specific genes contain
Fli-1 consensus binding sites in their promoters. There- Jacobsen and Paris-Trousseau syndrome are associ-
ated with a constellation of clinical defects, includingfore, we examined the expression of several genes that
contain potential Fli-1 binding sites and that are known severe heart abnormalities (Grossfeld et al., 1999), trigo-
nocephaly, mental retardation, dysmorphogenesis ofto bind ETS proteins in vitro. Expression of the endothe-
lial-restricted genes Tie (Iljin et al., 1999), Tek/Tie-2 the hands and face, thrombocytopenia (Penny et al.,
1995), and deletions of the long arm of chromosome 11,(Dube et al., 1999), and VEGFR-1/Flt-1 (Wakiya et al.,
1996) and the megakaryocyte-specific genes GpIX (Bas- where the human Fli-1 gene is located (Tunnacliffe et al.,
1999). We therefore examined more closely 14 patientstian et al., 1996), GpIIb (Zhang et al., 1993), c-mpl (De-
veaux et al., 1996), and vwf (Schwachtgen et al., 1997) diagnosed with Jacobsen syndrome, all of whom exhib-
ited defects in megakaryopoiesis determined by lightwas assessed by semiquantitative reverse transcriptase
polymerase chain reaction (RT-PCR) of E11.5 whole- and electron microscopy (data not shown). To define
precisely the extent of deletions in these patients, weembryo mRNA from Fli-11/2 and Fli-12/2 littermates. Ex-
pression of flk-1, flt-1, Tie, GpIIb, c-mpl, and vwf was performed fluorescence in situ hybridization (FISH) us-
ing a set of PAC clones derived from an 11q YAC contignot altered in Fli-12/2 mutants. In contrast, the levels of
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Figure 4. Analysis of Megakaryopoiesis in
Fli-12/2 Fetal Liver
(A) Relative numbers of megakaryocyte col-
ony-forming units (CFU-Mk) in wild-type and
Fli-1 mutant mice. Hematopoietic progenitors
from E11.5 fetal livers were cultured for 6 days
in the presence of Tpo, IL-3, IL-6, and IL-11.
Megakaryocyte colonies were identified by
staining for AChE activity. n, number of em-
bryos analyzed; *p . 0.0001, unpaired t test.
(B) Fli-12/2 AchE-positive CFU-Mk. Fli-12/2
colonies often showed immature megakaryo-
cyte phenotypes including reduced staining,
small nuclei, and high nucleus/cytoplasmic
ratio.
(C) Fli-11/2 AchE-positive colony after 6 days
in culture.
(D) Transmission electron micrograph (TEM)
of Fli-11/2 fetal liver megakaryocyte (scale
bar 5 5000 nm). The inset is a higher magnifi-
cation of the cytoplasm (large arrow) a gran-
ule; (Nu) nucleus; (small arrow) platelet de-
marcation membrane (scale bar 5 2000 nm).
(E) Fli-12/2 megakaryocyte from E11.5 fetal
liver (scale bar 5 5000 nm). The insert shows
a higher magnification of the cytoplasm with
few a granules present and disorganized
platelet demarcation membranes (scale bar 5
1000 nm).
(Tunnacliffe et al., 1999). All 14 of the patients had termi- situ differentiation of primary angioblasts to form vascu-
lar channels (vasculogenesis), followed by the prolifera-nal deletions of varying sizes of the long arm of chro-
mosome 11 with breakpoints centromeric to Fli-1 and tion and sprouting of existing vascular endothelial cells
to complete the circulatory system (angiogenesis) (Ri-therefore resulting in the hemizygous loss of this gene
(Figure 6). sau and Flamme, 1995). Embryos lacking Fli-1 are able
to form a functional network of blood vessels, indicating
that the initial stages of vasculogenesis and angiogen-Discussion
esis can proceed in the absence of this transcription
factor. Late embryonic angiogenesis and vascular re-Transcriptional activation of Fli-1 by either chromosomal
modeling are dependent on recruitment of pericytes andtranslocation or proviral insertion leads to Ewings sar-
smooth muscle cells to form the blood vessel wall (Risaucoma in children and erythroleukemia in mice, re-
and Flamme, 1995). In the brain, where vascularizationspectively. We have shown previously that Fli-1 over-
occurs following angiogenic sprouting, pericytes andexpression in the lymphoid compartment can induce
smooth muscle cells are recruited from the cephaliclymphopoiesis and autoimmune disease in the kidneys
mesenchyme and neural crest. Our previous studiesof transgenic mice (Zhang et al., 1995). In Xenopus, Fli-1
have shown that Fli-1 is expressed in both the endothe-overexpression disrupts embryonic polarity, inhibits
lial and putative neural crest lineages (Melet et al., 1996).erythropoiesis, and results in phenotypes suggestive
Therefore, it is possible that Fli-1 plays a role in theof altered cell adhesion properties (Remy et al., 1996).
expression of guidance cues and/or the modification ofTherefore, Fli-1 can affect developmental programs in
cellular adhesion properties in migrating vascular sup-a variety of cell lineages, and dysregulation of this tran-
port cells, or in the endothelial cells themselves. In orderscription factor in humans and mice results in tumori-
to decide whether the requirement for Fli-1 is intrinsicgenesis. In this study, we have assessed the biological
to endothelial cells or is indirect through supportingfunction of Fli-1, a member of the ETS family of transcrip-
cells, we analyzed the ability of Fli-12/2 cells to contributetion factors, by generating mice with a targeted null
to the developing vasculature in chimeric animals con-mutation in the Fli-1 gene. The results described here
taining a mixture of Fli-12/2 and Fli-11/1 cells. This analy-demonstrate that Fli-1 is essential for embryogenesis
sis clearly demonstrated that the absence of Fli-1 leadsand that the absence of Fli-1 affects both vascular devel-
to an intrinsic or cell-autonomous defect resulting inopment and megakaryopoiesis, resulting in loss of blood
the presence of Fli-12/2 cells in the vasculature of E10.5vessel integrity after embryonic day 11 and a partial
embryos but their absence by E14.5. We conclude thatblock in megakaryocyte differentiation.
Fli-1 plays an essential role in endothelial cells at thisThe formation of blood vessels within the developing
embryo is a two-stage process characterized by the in stage of development.
Fli-1 in Vascular Development and Megakaryopoiesis
173
Figure 6. Mapping of Chromosome 11q Deletions in 14 Jacobsen
Patients with Dysmegakaryopoiesis
(Solid bar) The extent of 11q retained in each individual is shown
with the most distal marker retained (1). (Shaded bar) Terminal
deletion breakpoint regions are shaded and the most proximal de-
leted marker is indicated (2). Patients 1±9 attended the Division of
Pediatric Hematology, Hopital D'enfants Armand Trousseau [R. F.],
and patients 10±14 were identified at the second annual 11q Re-
search and Resource conference in 1998 at the University of Califor-
nia, San Diego [P. G. and K. C.]. Patients 1 and 3 are from Jones
et al. (2000).
within the embryo has not been examined. It will be
of interest to determine whether the vascular defects
observed in both Fli-1 and Tel mutant embryos reflect
biochemical interactions between these two ETS pro-
teins in vivo.
In addition to the ETS family of transcription factors,
embryonic vasculogenesis and angiogenesis requireFigure 5. Downregulation of Potential Fli-1 Target Genes in Mutant
signaling through a number of receptor tyrosine kinasesEmbryos
(Risau, 1998). Null mutations generated by ourselvesSemiquantitative RT-PCR analysis of endothelial- and megakaryo-
and others in the endothelial-specific receptor tyrosinecyte-specific genes in Fli-11/2 and Fli-12/2 embryos. Equalized cDNA
kinases Flk-1 (Shalaby et al., 1995), Tie (Puri et al., 1995),samples from E11.5 embryos were analyzed by competitive PCR
and Tek/Tie-2 (Dumont et al., 1994) have revealed anfor hprt and potential Fli-1 target genes. (Fli-1) Fli-1 transcript is
absent in Fli-12/2 embryo; (flk-1) endothelial lineage marker; (Tie, essential requirement for these receptors in the develop-
Tek/Tie-2, and flt-1) endothelial-specific, potential Fli-1 target ment and maintenance of the vasculature. In particular,
genes; (AchE) megakaryocyte lineage marker; (GpIIb, c-mpl, and it is interesting to note that embryos lacking the Tek/
GpIX) megakaryocyte-specific, potential Fli-1 target genes. Tie-2 receptor die at approximately the same time as
the Fli-12/2 embryos described here. Importantly, we
observed that Tek/Tie-2 was specifically downregulated
Other members of the ETS gene family have also been in Fli-12/2 mutant embryos compared to their heterozy-
implicated in the regulation of angiogenesis in develop- gous Fli-11/2 littermates. The reduction of Tek/Tie-2 RNA
ment and neoplasia. For example, germline mutation in transcripts in Fli-12/2 embryos was not simply due to
the widely expressed ETS gene Tel causes defective the loss of endothelial cells in these dying embryos, as
angiogenesis in the embryonic yolk sac and apoptosis the expression of both Flk-1 and Tie, two other receptor
of mesenchymal and neural cells resulting in embryonic tyrosine kinases whose expression is entirely restricted
death at E10.5±E11.5 (Wang et al., 1997). TEL is a tran- to endothelial cells, was unaffected in these embryos.
scription factor whose activity is modulated by dimeriza- Recent in vitro experiments have demonstrated that ETS
tion with the Fli-1 protein (Kwiatkowski et al., 1998) and binding sites in the Tek/Tie-2 promoter regulate tran-
possibly other members of the ETS family of transcrip- scription of this gene (Dube et al., 1999). Therefore, the
tion factors that contain a ªpointedº domain. Heterodi- Tek/Tie-2 receptor may be directly regulated by Fli-1 in
merization of Fli-1 with Tel inhibits the transactivational endothelial cells, and loss of Tek/Tie-2 expression may
activity of the Fli-1 protein. We observed normal yolk sac be contributing to the loss of vascular integrity that we
observed in homozygous Fli-12/2 embryos.vascularization in Fli-12/2 embryos, although apoptosis
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Defects in megakaryopoiesis can result in internal membranes is common in both Jacobsen patients and
hemorrhaging due to lack of functional platelets and hence Fli-12/2 mice. The pleiotropic variability associated with
may have contributed to the fatal bleeding observed in Jacobsen syndrome may reflect the underlying molecu-
the Fli-12/2 embryos. We observed high levels of Fli-1 ex- lar variability in the extent and number of genes deleted
pression in megakaryocytes and have previously shown in different patients. Thus, Jacobsen syndrome may be
that the promoter of the megakaryocyte-specific GpIIb a contiguous gene disorder where the collection of phe-
gene contains a functional binding site for Fli-1 (Zhang notypes reflects the extent of gene deletion. In this
et al., 1993). There is also in vitro evidence that Fli-1 is study, we characterize the extent of deletions in 11q in
involved in megakaryocyte ontogeny. Overexpression a subset of patients, all of whom exhibited dysmega-
of Fli-1 in human K562 cells can induce differentiation karyopoiesis and thrombocytopenia. In doing so, we
along the megakaryocyte lineage, and, when differentia- have identified a minimal region for dysmegakaryo-
tion is induced with 12-O-tetradecanoylphorbol-13-ace- poiesis and thrombocytopenia in Jacobsen syndrome
tate (TPA), Fli-1 is upregulated (Athanasiou et al., 1996). that results in the loss of Fli-1 at 11q24. Therefore, it is
Fli-1 expression is also upregulated following Friend likely that hemizygous loss of Fli-1 contributes to the
murine erythroleukemia virus (F-MuLV) integration (Ben bleeding disorder that results from defective megakary-
David et al., 1991), and the resulting erythroleukemia opoiesis in many Jacobsens patients, and further under-
cell lines express the megakaryocytic genes AchE, PF4, standing of the molecular pathways that regulate mega-
GpIIb, and VWF (Paoletti et al., 1995). Members of the karyocyte differentiation and function may provide
ETS family, including Fli-1, bind enhancer sites and access to diagnostic and therapeutic intervention in
upregulate transcription of these and other megakaryo- these individuals and other thrombocytic diseases.
cyte-specific genes. For example, platelet factor 4 (PF4)
(Minami et al., 1998), glycoprotein IIB (GpIIb) (Zhang et Experimental Procedures
al., 1993), Von Willebrand factor (Schwachtgen et al.,
1997), glycoprotein IX (GpIX) (Bastian et al., 1999), and Standard cloning techniques were used to generate all plasmid
the thrombopoietin receptor (c-mpl) (Mignotte et al., constructs (Sambrook et al., 1989). Details of plasmid constructs
are available upon request.1994) are all directly regulated by ETS proteins in vitro.
Transcription of the GpIX gene was significantly reduced
in Fli-12/2 embryos, and megakaryocyte progenitors de- Targeted Disruption of the Murine Fli-1 Gene
rived from the livers of E11.5 Fli-12/2 embryos were in- Overlapping Fli-1 genomic clones were isolated from a l DASH II
mouse ES cell genomic library using the Fli-1 cDNA probe (Bencreased in number and compromised in their capacity
David et al., 1991). The exon/intron structure was determined byto differentiate. Recent studies have shown that expres-
restriction enzyme mapping and DNA sequencing. To generate thesion of the VWF receptor complex, consisting of GpIb/
first targeting construct (PNTFliZ), a 2.5 kb HindIII-EcoRI fragmentGpIX dimers, may regulate megakaryocyte proliferation
containing Fli-1 59 genomic DNA and a 3.1 kb HindIII fragment con-(Feng et al., 1999). This receptor is expressed late in
taining 39 genomic DNA were cloned into pPNT. A 4 kb EcoRI frag-
megakaryocyte differentiation and is thought to be re- ment containing a lacZ reporter cassette was then inserted, in frame
quired for apoptosis and platelet release. Therefore, the with Fli-1 exon VII. The second targeting vector (FliresZ) was con-
downregulation of GpIX expression in Fli-12/2 megakary- structed by inserting a 2.7 kb 59 NotI-EcoRI, a 2.8 kb 39 HindIII
ocytes may be contributing to the increased numbers fragment, an IRES-lacZ reporter cassette, and puromycin-resis-
of immature megakaryocytes that we observed in the tance cassette into pPNT. The two targeting constructs were linear-
ized with NotI and XhoI, respectively, and electroporated into RIin vitro megakaryocyte progenitor assays.
(Nagy and Rossant, 1993) ES cells. Transfectants were selected inOther transcription factors, including GATA-1 (Shivda-
G418 (100 mg/ml) and gancyclovir (2 mM) or G418 and puromycinsani et al., 1997), NF-E2 (Shivdasani et al., 1995), and
(2 mg/ml) and expanded for Southern blot analysis. The frequencythe GATA-1 cofactor, Friend of GATA-1 (FOG) (Tsang et
of homologous recombination with each targeting vector was 1 inal., 1998), are also required for megakaryocyte differenti-
400 and 1 in 250, respectively. Two independently generated, tar-
ation. Mice carrying a megakaryocyte-specific deletion geted ES cell clones were aggregated with CD-1 morula stage em-
of the GATA-1 gene exhibit increased megakaryopoiesis bryos. Male chimeras were mated to CD-1 and C57BL/6 females,
and a partial block in differentiation (Vyas et al., 1999). and heterozygous offspring were intercrossed to generate homozy-
Interestingly, our Fli-12/2 mice have a similar increase gous mutants. Genotyping of pups and embryos was by Southern
in immature megakaryocytes. Similarly, Fli-12/2 and blot analysis and PCR. No differences in the E11.5 cerebral bleeding
phenotype were observed between mice derived from the two inde-GATA-12/2 megakaryocytes both display reduced a
pendent ES cell clones, nor between mice of different genetic back-granule content and loss of organization of platelet de-
grounds (mixed 129/Sv-C57BL/6 or 129/Sv-CD-1).marcation membranes. Furthermore, megakaryocyte-
specific genes, including PF4 (Minami et al., 1998), GpIIb
Generation of Fli-12/2 ES Cells(Zhang et al., 1993), and c-mpl (Deveaux et al., 1996),
Heterozygous Fli-11/2 ES cell clones were passaged on gelatin-carry both ETS and GATA-1 consensus binding sites.
treated plates, and homozygous mutant Fli-12/2 ES cell clones wereTaken together, these findings suggest that Fli-1 and
generated following electroporation of the FliresZ construct andGATA-1 may cooperate in regulating megakaryopoiesis.
selection in G418 and puromycin. Fli-12/2 ES clones were identifiedThe dysmegakaryopoiesis and thrombocytopenia as-
by Southern blot analysis.
sociated with Jacobsen syndrome and Paris-Trousseau
syndrome is characterized by an increased number of
Western Blot Analysisbone marrow megakaryocytes, including numerous mi-
Protein extracted from E9.5 whole embryos was homogenized andcromegakaryocytes (mMKs) and platelets in the periph- sonicated on ice three times for 15 s. The homogenate was spun
eral blood containing giant a granules resulting from a for 15 min, and the supernatant was quantitated by BCA assay
granule fusion (Breton-Gorius et al., 1995). The Fli-12/2 (Bio-Rad), according to manufacturer's protocols. Total protein was
mice have a similar increase in small, immature mega- loaded in each lane of a 10% polyacrylamide gel, followed by trans-
karyocytes and display abnormal a granule biosynthe- fer onto nitrocellulose and blocking in 5% nonfat milk in TBS over-
night. Rabbit polyclonal Fli-1 antiserum (Zhang et al., 1993) wassis. In addition, disorganization of platelet demarcation
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